Consequences of chronic 5-hydroxy-tryptophan in parkinsonian instability of gait and balance and in other neurological disorders.
D006916:5-Hydroxytryptophan / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001545:Benserazide / Q000627:therapeutic use; D002524:Cerebellar Ataxia / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D005684:Gait; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D004856:Postural Balance / Q000187:drug effects*
D001545:Benserazide; D006916:5-Hydroxytryptophan